Ishibashi Toru | Department Of Clinical Pharmacology And Pharmacokinetics Developmental Research Laboratories Shionog
スポンサーリンク
概要
- ISHIBASHI Toruの詳細を見る
- 同名の論文著者
- Department Of Clinical Pharmacology And Pharmacokinetics Developmental Research Laboratories Shionogの論文著者
関連著者
-
Oguma T
Developmental Research Laboratories Shionogi & Co. Ltd.
-
Oguma Takayoshi
Developmental Research Laboratories Shionogi & Co. Ltd.
-
Yano Yoshitaka
Developmental Research Laboratories Shionogi & Co. Ltd.
-
Yano Yoshitaka
Department Of Clinical Pharmacology And Pharmacokinetics Developmental Research Laboratories Shionog
-
Ishibashi Toru
Department Of Clinical Pharmacology And Pharmacokinetics Developmental Research Laboratories Shionog
-
OGUMA TAKAYOSHI
Department of Pharmacology, School of Medicine, Showa University
-
Oguma Takayoshi
Department Of Pharmacology School Of Medicine Showa University:shionogi Research Laboratories Shiono
-
Oguma Takayoshi
Developmental Research Laboratories Shionogi
-
OHNISHI Ayako
Developmental Research Laboratories, Shionogi & Co., Ltd.
-
YANO Yoshitaka
Developmental Research Laboratories, Shionogi & Co., Ltd.
-
ISHIBASHI Toru
Developmental Research Laboratories, Shionogi & Co., Ltd.
-
KATSUBE Takayuki
Developmental Research Laboratories, Shionogi & Co., Ltd.
-
ISHIBASHI Toru
Department of Clinical Pharmacology and Pharmacokinetics Developmental Research Laboratories, Shiono
-
FUKUMURA Kazuya
Department of Clinical Pharmacology and Pharmacokinetics Developmental Research Laboratories, Shiono
-
YANO Yoshitaka
Department of Clinical Pharmacology and Pharmacokinetics Developmental Research Laboratories, Shiono
-
Katsube Takayuki
Developmental Research Laboratories Shionogi & Co. Ltd.
-
Ohnishi A
Developmental Research Laboratories Shionogi & Co. Ltd.
-
Fukumura Kazuya
Department Of Clinical Pharmacology And Pharmacokinetics Developmental Research Laboratories Shionog
著作論文
- Evaluation of Bayesian Predictability of Vancomycin Concentration Using Population Pharmacokinetic Parameters in Pediatric Patients
- The optimal dosage regimen of nedaplatin based on pharmacokinetics and toxicodynamics